PB: Clinical Trials

4 trials of PB, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 unknown. 2 Not applicable, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 1, Unknown 1
Phase 22Completed 2

Follow PB: new trials by email Literature Review of PB trials Research Report on PB

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of REGN7544 for the Treatment in Adult Patients With Sepsis-Induced Hypotension
REGN7544, PB - Sepsis-Induced Hypotension
Phase 2CompletedRegeneron Pharmaceuticals762025-05-052026-05-20
Probenecid (PB) to Treat Hereditary Nephrogenic Diabetes Insipidus (NDI), ADPKD Treated With Tolvaptan, and Severely Polyuric Patients With Previous Lithium Administration
PB - Autosomal Dominant Polycystic Kidney Disease, Nephrogenic Diabetes Insipidus
Phase 2CompletedMayo Clinic362022-09-012026-01-27
Impact Evaluation of Incisional Hernia on Muscular and Postural Function
Dynamometric tension assessment, Postural balance, Assessment of the hernia defect size - Incisional Hernia
Not applicableCompletedRepublican Specialized Scientific and Practical Medical Center of Surgery Named After V. Vakhidov952018-01-022023-08-14
High Protein Breakfast on Postprandial Glycemia in T2D (PBD)
Arm1: Whey protein, Arm 2 Breakfast- other proteins, Arm 3 Breakfast- low protein - Type 2 Diabetes
Not applicableUnknownHospital de Clinicas Caracas602012-08-012016-08-03

Conditions studied

Diabetes Insipidus (1)  ·  Diabetes Insipidus, Nephrogenic (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Hypotension (1)  ·  Incisional Hernia (1)  ·  Polycystic Kidney Diseases (1)  ·  Polycystic Kidney, Autosomal Dominant (1)

Sponsors

Hospital de Clinicas Caracas (1)  ·  Mayo Clinic (1)  ·  Regeneron Pharmaceuticals (1)  ·  Republican Specialized Scientific and Practical Medical Center of Surgery Named After V. Vakhidov (1)

Countries

United States (2)  ·  France (1)  ·  Uzbekistan (1)

Top investigators

Daniela Jakubowicz, MD (1)  ·  Fouad Chebib, MD (1)  ·  Otabek J. Eshonkhodjaev, MD, PhD (1)